Elastrin Therapeutics
Simpsonville
About Elastrin Therapeutics
Elastrin Therapeutics is a biotech startup with technologies to restore hardened and damaged arteries & tissue by targeting the elastic fiber that makes them work. The company's proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $20.8M
- Last round: Series Unknown (Nov 2023)
- Website: elastrin.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/elastrin-therapeutics-9536 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.